HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.

Abstract
Familial dysautonomia (FD) is caused by an intronic splice mutation in the IKBKAP gene that leads to partial skipping of exon 20 and tissue-specific reduction in I-κ-B kinase complex-associated protein/elongation protein 1 (IKAP/ELP-1) expression. Kinetin (6-furfurylaminopurine) has been shown to improve splicing and increase WT IKBKAP mRNA and IKAP protein expression in FD cell lines and carriers. To determine whether oral kinetin treatment could alter mRNA splicing in FD subjects and was tolerable, we administered kinetin to eight FD individuals homozygous for the splice mutation. Subjects received 23.5 mg/Kg/d for 28 d. An increase in WT IKBKAP mRNA expression in leukocytes was noted after 8 d in six of eight individuals; after 28 d, the mean increase compared with baseline was significant (p = 0.002). We have demonstrated that kinetin is tolerable in this medically fragile population. Not only did kinetin produce the desired effect on splicing in FD patients but also that effect seems to improve with time despite lack of dose change. This is the first report of a drug that produces in vivo mRNA splicing changes in individuals with FD and supports future long-term trials to determine whether kinetin will prove therapeutic in FD patients.
AuthorsFelicia B Axelrod, Leonard Liebes, Gabrielle Gold-Von Simson, Sandra Mendoza, James Mull, Maire Leyne, Lucy Norcliffe-Kaufmann, Horacio Kaufmann, Susan A Slaugenhaupt
JournalPediatric research (Pediatr Res) Vol. 70 Issue 5 Pg. 480-3 (Nov 2011) ISSN: 1530-0447 [Electronic] United States
PMID21775922 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Elp1 protein, human
  • RNA, Messenger
  • Transcriptional Elongation Factors
  • Kinetin
Topics
  • Administration, Oral
  • Adult
  • Analysis of Variance
  • Area Under Curve
  • Carrier Proteins (genetics, metabolism)
  • Dysautonomia, Familial (genetics, physiopathology)
  • Female
  • Gene Expression Regulation (drug effects)
  • Humans
  • Kinetin (administration & dosage, blood, pharmacokinetics, pharmacology)
  • Male
  • New York
  • RNA Splicing (drug effects, physiology)
  • RNA, Messenger (metabolism)
  • Transcriptional Elongation Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: